Bearish signal on weekly chart
Company has spent 2.36% of its operating revenues towards interest expenses and 13.08% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Company has spent 2.36% of its operating revenues towards interest expenses and 13.08% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Black Spinning Top was formed for Apollo Hospital
Stock gave a 3 year return of 82.32% as compared to Nifty 100 which gave a return of 48.83%. (as of last trading session)
Stock generated 82.32% return as compared to BSE Healthcare which gave investors 81.25% return over 3 year time period. (as of last trading session)
Apollo Hospitals Enterprise Ltd. share price moved down by -1.90% from its previous close of Rs 6,851.50. Apollo Hospitals Enterprise Ltd. stock last traded price is 6,722.00
Share Price | Value |
---|---|
Today/Current/Last | 6,722.00 |
Previous Day | 6,851.50 |
PE Ratio (x) | 73.77 | ||||||||||
EPS - TTM (₹) | 91.12 | ||||||||||
MCap (₹ Cr.) | 96,652.05 | ||||||||||
Sectoral MCap Rank | 2 | ||||||||||
PB Ratio (x) | 13.46 | ||||||||||
Div Yield (%) | 0.24 | ||||||||||
Face Value (₹) | 5.00 | ||||||||||
Beta Beta
| 1.67 | ||||||||||
VWAP (₹) | 6,725.28 | ||||||||||
52W H/L (₹) |
1 Day | -1.9% |
1 Week | -3.34% |
1 Month | -1.64% |
3 Months | -1.01% |
1 Year | 15.77% |
3 Years | 78.48% |
5 Years | 411.26% |
Thousands of crores are coming for Ram Charan’s wife, Upasana. She is not shopping but studying!
Report warns lifestyle diseases epidemic among Indians, calls for preventive healthcare
Apollo Hospitals shares in focus as subsidiary raises stake in Keimed for Rs 625 crore
Board Meeting Intimation for Notice Of Board Meeting
AnnouncementsCurrent
Mean Recos by 24 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 7 |
Buy | 12 | 12 | 12 | 12 |
Hold | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 3 |
Strong Sell | - | - | - | - |
# Analysts | 24 | 24 | 24 | 24 |
Employee & Interest Expense
Company has spent 2.36% of its operating revenues towards interest expenses and 13.08% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)Quarterly | Annual | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|---|
Total Income | 5,590.70 | 5,627.50 | 5,122.80 | 4,972.00 | 4,878.40 |
Total Income Growth (%) | -0.65 | 9.85 | 3.03 | 1.92 | 0.19 |
Total Expenses | 4,950.00 | 4,958.30 | 4,587.90 | 4,493.10 | 4,403.90 |
Total Expenses Growth (%) | -0.17 | 8.07 | 2.11 | 2.03 | 0.53 |
EBIT | 640.70 | 669.20 | 534.90 | 478.90 | 474.50 |
EBIT Growth (%) | -4.26 | 25.11 | 11.69 | 0.93 | -2.81 |
Profit after Tax (PAT) | 372.30 | 378.80 | 305.20 | 253.80 | 245.30 |
PAT Growth (%) | -1.72 | 24.12 | 20.25 | 3.47 | 5.32 |
EBIT Margin (%) | 11.46 | 11.89 | 10.44 | 9.63 | 9.73 |
Net Profit Margin (%) | 6.66 | 6.73 | 5.96 | 5.10 | 5.03 |
Basic EPS (₹) | 25.89 | 26.34 | 21.23 | 17.65 | 17.06 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Assets | 16,753.10 | 14,427.80 | 13,192.40 | 11,416.70 | 11,338.40 |
Total Assets Growth (%) | 16.12 | 9.36 | 15.55 | 0.69 | 23.47 |
Total Liabilities | 9,432.60 | 7,896.50 | 7,314.70 | 6,614.30 | 7,868.60 |
Total Liabilities Growth (%) | 19.45 | 7.95 | 10.59 | -15.94 | 37.70 |
Total Equity | 7,320.50 | 6,531.30 | 5,877.70 | 4,802.40 | 3,469.80 |
Total Equity Growth (%) | 12.08 | 11.12 | 22.39 | 38.41 | 0.03 |
Current Ratio (x) | 1.13 | 1.30 | 1.73 | 1.79 | 1.13 |
Total Debt to Equity (x) | 0.46 | 0.44 | 0.47 | 0.54 | 1.00 |
Contingent Liabilities | 789.90 | 732.40 | 658.10 | 1,636.00 | 651.60 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 1537.2 cr for investing activities which is an YoY increase of 76.57%. (Source: Consolidated Financials)Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 1,920.20 | 1,376.70 | 1,628.00 | 1,273.40 | 1,292.80 |
Net Cash used in Investing Activities | -1,537.20 | -870.60 | -778.20 | -872.30 | -288.80 |
Net Cash flow from Financing Activities | -311.10 | -633.00 | -792.60 | -340.10 | -909.50 |
Net Cash Flow | 72.00 | -113.10 | 157.80 | 44.50 | 94.50 |
Closing Cash & Cash Equivalent | 505.40 | 433.40 | 583.00 | 425.20 | 380.70 |
Closing Cash & Cash Equivalent Growth (%) | 16.61 | -25.66 | 37.11 | 11.69 | 33.01 |
Total Debt/ CFO (x) | 1.65 | 1.97 | 1.62 | 1.96 | 2.59 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Return on Equity (%) | 12.95 | 13.21 | 18.77 | 3.26 | 13.62 |
Return on Capital Employed (%) | 14.97 | 13.73 | 15.38 | 6.49 | 11.04 |
Return on Assets (%) | 5.36 | 5.67 | 8.00 | 1.31 | 4.01 |
Interest Coverage Ratio (x) | 5.56 | 5.62 | 5.98 | 1.36 | 1.87 |
Asset Turnover Ratio (x) | 1.22 | 0.54 | 0.56 | 92.49 | 99.19 |
Price to Earnings (x) | 102.04 | 75.76 | 61.73 | 277.78 | 34.84 |
Price to Book (x) | 13.17 | 10.00 | 11.55 | 9.07 | 4.74 |
EV/EBITDA (x) | 37.63 | 30.02 | 29.51 | 36.97 | 11.68 |
EBITDA Margin (%) | 13.10 | 12.88 | 15.43 | 11.19 | 14.35 |
Bullish / Bearish signals for Apollo Hospital basis selected technical indicators and moving average crossovers.
Stochastic Crossover
Bearish signal on weekly chart
Appeared on: 9 May 2025
Region: Equlibrium
Date | 7 weeks Gain/Loss % |
---|---|
13 Mar 2025 | -1.70% |
10 Jan 2025 | -11.68% |
14 Nov 2024 | -3.88% |
4 Oct 2024 | -0.45% |
Average price decline of -5.85% within 7 weeks of Bearish signal in last 10 years
50 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 9 May 2025
50D EMA: 6778.22
Date | 30 days Gain/Loss % |
---|---|
27 Mar 2025 | -0.91% |
8 Jan 2025 | -7.49% |
28 Nov 2024 | -0.43% |
13 Nov 2024 | -3.86% |
Average price decline of -3.61% within 30 days of Bearish signal in last 5 years
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 6818.17 | 6914.33 | 7080.83 | 6747.83 | 6651.67 | 6581.33 | 6414.83 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 144.46 | 141.62 | 142.46 |
Stock Returns vs Nifty 100
Stock gave a 3 year return of 82.32% as compared to Nifty 100 which gave a return of 48.83%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 82.32% return as compared to BSE Healthcare which gave investors 81.25% return over 3 year time period. (as of last trading session)Choose from Peers
Choose from Stocks
Stock Returns vs Nifty 100
Stock gave a 3 year return of 82.32% as compared to Nifty 100 which gave a return of 48.83%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 82.32% return as compared to BSE Healthcare which gave investors 81.25% return over 3 year time period. (as of last trading session)1,075.13
Amount Invested (in Cr.)
1.54%
% of AUM
0.00
% Change (MoM basis)
478.89
Amount Invested (in Cr.)
1.27%
% of AUM
3.43
% Change (MoM basis)
470.98
Amount Invested (in Cr.)
2.73%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 March 2025
Price
6,745.50-122.50 (-1.78%)
Open Interest
24,33,37513,375 (0.55%)
Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
---|---|---|---|---|---|
6,743.50 | 6,855.00 | 6,692.00 | 6,868.00 | 2,608 | 22,001.68 |
Open Interest as of 09 May 2025
Price
154.05-81.45 (-34.59%)
Open Interest
11,2508,750 (350.00%)
Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
---|---|---|---|---|---|
194.90 | 194.90 | 138.15 | 235.50 | 275 | 2,347.29 |
Open Interest as of 09 May 2025
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
May 30, 2025 | May 06, 2025 | Board Meeting | Audited Results, Final Dividend & A.G.M. |
Feb 10, 2025 | Feb 05, 2025 | Board Meeting | Quarterly Results & Interim Dividend |
Nov 06, 2024 | Oct 15, 2024 | Board Meeting | Quarterly Results |
Aug 19, 2024 | Jul 15, 2024 | POM | - |
Aug 13, 2024 | Jul 31, 2024 | Board Meeting | Quarterly Results |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Interim | 180% | 9.0 | Feb 14, 2025 | Feb 10, 2025 |
Final | 200% | 10.0 | Aug 16, 2024 | May 30, 2024 |
Interim | 120% | 6.0 | Feb 20, 2024 | Feb 08, 2024 |
Final | 180% | 9.0 | Aug 18, 2023 | May 30, 2023 |
Final | 120% | 6.0 | Feb 24, 2023 | Feb 14, 2023 |
All Types | Ex-Date | Record Date | Announced on | Details |
---|---|---|---|---|
Splits | Sep 02, 2010 | Sep 03, 2010 | May 28, 2010 | Split: Old FV10.0| New FV:5.0 |
Rights | Mar 10, 1993 | Apr 09, 1993 | Sep 30, 1993 | Rights ratio: 1 share for every 1 held at a price of Rs 20.0 |
Apollo Hospitals Enterprise Ltd., incorporated in the year 1979, is a Large Cap company (having a market cap of Rs 96,652.05 Crore) operating in Hospitals & Allied Services sector. Apollo Hospitals Enterprise Ltd. key Products/Revenue Segments include HealthCare Services and Other Operating Revenue for the year ending 31-Mar-2024. Show More
Prathap C Reddy
Founder & Executive ChairmanPreetha Reddy
Executive Vice ChairpersonSuneeta Reddy
Managing DirectorSangita Reddy
Joint Managing DirectorIndustry
Key Indices Listed on
Nifty 50, Nifty 100, Nifty 200, + 37 more
Address
No.19, Bishop Gardens,Raja Annamalaipuram,Chennai (Madras), Tamil Nadu - 600028
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.